247 related articles for article (PubMed ID: 35241552)
41. Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba.
Molina-Águila N; Cruz-Rodríguez E; Ferrán-Torres RM; Galindo-Santana BM; López-Almaguer Y; Romero-Placeres M
MEDICC Rev; 2021 Apr; 23(2):15. PubMed ID: 33974611
[TBL] [Abstract][Full Text] [Related]
42. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
[TBL] [Abstract][Full Text] [Related]
43. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
44. Real world outcomes in cancer patients with COVID-19 infection: Northern Ireland experience.
Feeney L; Hamilton A; Lavery A; O'Neill C; Walls G; Taylor K; Turkington RC
Ulster Med J; 2023 Jan; 92(1):29-37. PubMed ID: 36762131
[TBL] [Abstract][Full Text] [Related]
45. Direct and indirect impacts of the COVID-19 pandemic on patients with pulmonary and pleural malignancies - a retrospective analysis of patient outcomes treated at Department of Respiratory Diseases, University Hospital Brno, during the 2nd and 3rd coronavirus waves.
Bratová M; Brat K; Jakubíková L
Klin Onkol; 2022; 35(3):215-221. PubMed ID: 35760574
[TBL] [Abstract][Full Text] [Related]
46. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.
Yassa M; Yirmibes C; Cavusoglu G; Eksi H; Dogu C; Usta C; Mutlu M; Birol P; Gulumser C; Tug N
J Matern Fetal Neonatal Med; 2020 Nov; 33(22):3820-3826. PubMed ID: 32691641
[TBL] [Abstract][Full Text] [Related]
47. Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies.
Tsimafeyeu I; Volkova M; Alekseeva G; Berkut M; Nosov A; Myslevtsev I; Andrianov A; Semenov A; Borisov P; Zukov R; Goutnik V; Savchuk S; Dengina N; Mitin T
J Hematol Oncol; 2021 Nov; 14(1):192. PubMed ID: 34774086
[TBL] [Abstract][Full Text] [Related]
48. The prevalence of asymptomatic COVID-19 infection in cancer patients. A cross-sectional study at a tertiary cancer center in New York City.
Ibrahim M; Natarajan V; Murthy P; Meghal T; Xu Y; Wiesel O
Cancer Treat Res Commun; 2021; 27():100346. PubMed ID: 33756172
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the demographic characteristics and comorbidities of patients with COVID-19 who died in Spanish hospitals based on whether they were or were not admitted to an intensive care unit.
Miró Ò; Alquézar-Arbé A; Llorens P; Martín-Sánchez FJ; Jiménez S; Martín A; Burillo-Putze G; Jacob J; García-Lamberechts EJ; Piñera P; Del Castillo JG;
Med Intensiva (Engl Ed); 2021; 45(1):14-26. PubMed ID: 33158594
[TBL] [Abstract][Full Text] [Related]
50. Meeting the Challenges in Cancer Care Management During the SARS-Cov-2 Pandemic: A Retrospective Analysis.
Rasschaert M; Vanclooster P; Depauw L; Mertens T; Roelant E; Coenen E; Anguille S; Janssens A; Van Dam P; Peeters M
Cancer Control; 2021; 28():10732748211045275. PubMed ID: 34623943
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series.
Preda A; Ciuleanu T; Kubelac P; Todor N; Balacescu O; Achimas-Cadariu P; Iancu D; Mocan C; Bandi-Vasilica M; Lupse M; Briciu VT; Man MA; Vlad C
ESMO Open; 2022 Apr; 7(2):100423. PubMed ID: 35279526
[TBL] [Abstract][Full Text] [Related]
52. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
[TBL] [Abstract][Full Text] [Related]
53. Maternal and perinatal characteristics and outcomes of pregnancies complicated with COVID-19 in Kuwait.
Ayed A; Embaireeg A; Benawadh A; Al-Fouzan W; Hammoud M; Al-Hathal M; Alzaydai A; Ahmad A; Ayed M
BMC Pregnancy Childbirth; 2020 Dec; 20(1):754. PubMed ID: 33267785
[TBL] [Abstract][Full Text] [Related]
54. COVID-19-related mortality in cancer patients in an Irish setting.
Linehan A; Fitzpatrick O; Cowzer D; Hennessy MA; Coyne ZL; Nolan A; Clarke M; Dhonaill RN; Hennessy BT; Morris PG; Grogan L; Breathnach O
Ir J Med Sci; 2022 Oct; 191(5):2013-2018. PubMed ID: 34697787
[TBL] [Abstract][Full Text] [Related]
55. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic.
Hartman HE; Sun Y; Devasia TP; Chase EC; Jairath NK; Dess RT; Jackson WC; Morris E; Li P; Hochstedler KA; Abbott MR; Kidwell KM; Walter V; Wang M; Wang X; Zaorsky NG; Schipper MJ; Spratt DE
JAMA Oncol; 2020 Dec; 6(12):1881-1889. PubMed ID: 33119036
[TBL] [Abstract][Full Text] [Related]
56. Survival study and factors associated with mortality in Chilean patients on peritoneal dialysis infected with SARS-CoV-2.
Ortiz AM; Sepúlveda RA; Torres R; Clavero R; Toro L; Albornoz M; Aldunate T; Arce I; Arévalo J; Arriagada A; Becker J; González SC; Bernales W; Briones E; Castillo Á; Fuentes A; Gómez E; Jaramillo H; Lillo M; Lorca E; Machuca E; Mansilla R; Menéndez S; Moya C; Muñoz C; Neilson W; Orozco R; Padrino M; Pais E; Ramírez G; Sanhueza ME; Schneider H; Solís R; Troncoso J; Ursu M; Valenzuela M
Perit Dial Int; 2022 Sep; 42(5):535-539. PubMed ID: 35352596
[TBL] [Abstract][Full Text] [Related]
57. Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival.
Tejedor-Tejada J; Gómez-Díez C; Robles Gaitero S; Villar Caamaño A; Hermida Pérez B; Olmos JM; Álvarez Álvarez A; Tojo González R
Rev Esp Enferm Dig; 2022 Aug; 114(8):509-510. PubMed ID: 35297265
[TBL] [Abstract][Full Text] [Related]
58. Impact of Covid-19 on the management of patients with metastatic melanoma.
Welti M; Cheng PF; Mangana J; Levesque MP; Dummer R; Imhof L
Oncotarget; 2022 Dec; 13():1370-1379. PubMed ID: 36580495
[TBL] [Abstract][Full Text] [Related]
59. Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients.
Ganti AK; Fillmore NR; Bihn J; La J; Brophy MT; Do NV; Kelley M
Int J Clin Oncol; 2023 Apr; 28(4):531-542. PubMed ID: 36859565
[TBL] [Abstract][Full Text] [Related]
60. Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.
Pantea Stoian A; Pricop-Jeckstadt M; Pana A; Ileanu BV; Schitea R; Geanta M; Catrinoiu D; Suceveanu AI; Serafinceanu C; Pituru S; Poiana C; Timar B; Nitipir C; Parvu S; Arsene A; Mazilu L; Toma A; Hainarosie R; Ceriello A; Rizzo M; Jinga V
Sci Rep; 2020 Dec; 10(1):21613. PubMed ID: 33303885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
